抗真菌藥物市場：依藥物類型、適應症、劑型、通路和地區分類。

預計到2026年，抗真菌藥物市場規模將達到155.5億美元，到2033年將達到200.6億美元。預計從2026年到2033年，其複合年成長率將達到3.7%。

抗真菌藥物用於治療真菌感染疾病。常見的真菌感染疾病，例如甲癬和體癬，通常發生在體表，但某些侵襲性真菌感染疾病會發生在肺部、腦部等內臟組織或器官內部。真菌感染疾病通常與免疫力低下者有關，例如愛滋病毒感染者/愛滋病患者。此外，接受化療的患者也更容易發生侵襲性真菌感染疾病。抗真菌藥物透過殺死真菌細胞或抑制其生長來對抗真菌感染疾病。抗真菌藥物大致可分為外用抗真菌藥物、口服抗真菌藥物、靜脈注射抗真菌藥物及陰道用抗黴菌栓劑。

市場動態

市場上的主要參與者正專注於透過合作和協議等成長策略來擴大市場佔有率。例如，2017年6月，生物製藥公司Basilea Pharmaceuticals與輝瑞和Avia Pharma簽署了一項協議，獲得了其抗真菌藥物的市場推廣權。輝瑞將在俄羅斯、以色列、歐洲（不包括北歐國家）和土耳其等地區生產和銷售這種用於治療危及生命的侵襲性真菌感染疾病的藥物。

同樣，市場上的主要參與者正專注於各種商業策略，包括研發，以拓展其產品系列。藥物研發的增加預計將推動該市場的成長。例如，2019年1月，生物技術公司SCYNEXIS, Inc.宣布了其正在進行的FURI試驗的首次中期療效分析的積極結果。這項新治療方法旨在治療真菌感染。

本次調查的主要特點

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要參與者採取的競爭策略。
• 本研究根據以下參數對全球抗真菌藥物市場的主要參與者進行了分析：公司概況、財務業績、產品系列、企業發展區域、分銷策略、關鍵發展和策略以及未來計劃。
• 透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
• 這份全球抗真菌藥物市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過利用分析全球抗真菌藥物市場中使用的各種策略矩陣，更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 市場機遇
• 影響分析
• 近期試飛
• 流行病學
• 併購和合作
• 監管趨勢
• 主要進展
• PEST分析

第4章 全球抗真菌藥物市場：依藥物類型分類，2021-2033年

• 棘白菌素類
• Polyenes
• Allylamines
• Azole
• 其他

第5章 全球抗真菌藥物市場：依適應症分類，2021-2033年

• 麴菌症
• 皮膚絲狀菌症
• 念珠菌症
• 白黴菌症
• 其他

第6章 全球抗真菌藥物市場：依劑型分類，2021-2033年

• 粉末
• 軟膏
• 注射藥物
• 藥片
• 其他

第7章 全球抗真菌藥物市場：依通路分類，2021-2033年

• 醫院藥房
• 網路藥房
• 零售藥房

第8章 全球抗真菌藥物市場：按地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 中東
  • GCC
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第9章 競爭情勢

• 公司簡介
  • GlaxoSmithKline Plc
  • Bayer AG
  • Abbott Laboratories
  • Merck & Co., Inc.
  • Glenmark Pharmaceuticals Limited
  • Enzon Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Gilead Sciences, Inc.
  • Sanofi SA
  • Astellas Pharma, Inc.
  • Alembic Pharmaceuticals Limited
  • SCYNEXIS, Inc.

第10章

• 參考
• 調查方法

Anti Fungal Drugs Market is estimated to be valued at USD 15.55 Bn in 2026 and is expected to reach USD 20.06 Bn by 2033, growing at a compound annual growth rate (CAGR) of 3.7% from 2026 to 2033.

Antifungal drugs are used to treat fungal infections in individuals. Common fungal infections such as fungal nail infection, and ringworm etc. usually occur on the external surface of the body, while certain invasive fungal infections occur inside the body tissues or inside internal organs such as lungs and brain. Fungal infection is usually associated with individuals having weak immune system, such as people suffering from HIV/AIDS. Moreover, patients undergoing chemotherapy are susceptible to invasive fungal infections. Antifungal drugs act against the fungal infections by either killing the fungal cells or by inhibiting their growth. Antifungal drugs are broadly classified as topical antifungals, oral antifungals, intravenous antifungals, and intravaginal antifungal pessaries.

Market Dynamics

Major players in the market are focused on growth strategies such as collaborations and agreements in order to enhance their market presence. For instance, in June 2017, Basilea Pharmaceutica Ltd., a biopharmaceutical company, entered into an agreement with Pfizer, Inc. and Avir Pharma, Inc. for the distribution rights of Beasilea's antifungal treatments. Pfizer will manufacture and distribute drugs for the treatment of life-threatening invasive mold infections in regions like Russia, Israel, Europe (excluding Nordics), and Turkey.

Similarly, key players in the market are focused on various business strategies such as research and development in order to expand their product portfolio. Increasing drug development is expected to drive growth of this market. For instance, in January 2019, SCYNEXIS, Inc., a biotechnology company, announced positive interim result from their first interim efficiency analysis of an ongoing FURI study. The development of this novel treatment is indicated for antifungal treatment.

Key features of the study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players.
• It profiles leading players in the global antifungal drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
• Key companies covered as a part of this study include GlaxoSmithKline Plc, Bayer AG, Abbott Laboratories, Merck & Co., Inc, Glenmark Pharmaceuticals Limited, Enzon Pharmaceuticals, Inc., Pfizer Inc., Gilead Sciences, Inc., Sanofi S.A., and Astellas Pharma, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
• The global antifungal drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antifungal drugs market.

Market Segmentation

• By Drug Type (Revenue, USD Bn, 2021 - 2033)
• Echinocandins
• Polyenes
• Allylamines
• Azoles
• Others
• By Application (Revenue, USD Bn, 2021 - 2033)
• Neurosurgery
• Plastic Surgery
• Cardiovascular Surgery
• Obstetrics & Gynecology
• Others
• By Indication (Revenue, USD Bn, 2021 - 2033)
• Aspergillosis
• Dermatophytosis
• Candidiasis
• Mucormycosis
• Others
• By Dosage Form (Revenue, USD Bn, 2021 - 2033)
• Powders
• Ointments
• Injections
• Tablets
• Others
• By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies
• By Region (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• GlaxoSmithKline Plc
• Bayer AG
• Abbott Laboratories
• Merck & Co., Inc.
• Glenmark Pharmaceuticals Limited
• Enzon Pharmaceuticals, Inc.
• Pfizer Inc.
• Gilead Sciences, Inc.
• Sanofi S.A.
• Astellas Pharma, Inc.
• Alembic Pharmaceuticals Limited
• SCYNEXIS, Inc.

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Drug Type
  • Market Snippet, By Indication
  • Market Snippet, By Dosage Form
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Test Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Anti Fungal Drugs Market, By Drug Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Echinocandins
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Segment Trends
• Polyenes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Segment Trends
• Allylamines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Segment Trends
• Azoles
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Segment Trends
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Segment Trends

5. Global Anti Fungal Drugs Market, By Indication, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Aspergillosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Segment Trends
• Dermatophytosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Segment Trends
• Candidiasis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Segment Trends
• Mucormycosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Segment Trends
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Segment Trends

6. Global Anti Fungal Drugs Market, By Dosage Form, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Powders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Ointments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Injections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Tablets
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Anti Fungal Drugs Market, By Distribution Channel, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Anti Fungal Drugs Market, By Region, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication,2021 - 2033, (USD Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication,2021 - 2033, (USD Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication,2021 - 2033, (USD Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication,2021 - 2033, (USD Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication,2021 - 2033, (USD Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication,2021 - 2033, (USD Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • GlaxoSmithKline Plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Bayer AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Merck & Co., Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Glenmark Pharmaceuticals Limited
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Enzon Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Gilead Sciences, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Sanofi S.A.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Astellas Pharma, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Alembic Pharmaceuticals Limited
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • SCYNEXIS, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies

10. Section

• References
• Research Methodology
• About us and Sales Contact